Akt-Mediated Transactivation of the S1P 1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids
- 24 April 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 104 (8) , 978-986
- https://doi.org/10.1161/circresaha.108.193367
Abstract
Endothelial cell (EC) barrier dysfunction results in increased vascular permeability, leading to increased mass transport across the vessel wall and leukocyte extravasation, the key mechanisms in pathogenesis of tissue inflammation and edema. We have previously demonstrated that OxPAPC (oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine) significantly enhances vascular endothelial barrier properties in vitro and in vivo and attenuates endothelial hyperpermeability induced by inflammatory and edemagenic agents via Rac and Cdc42 GTPase dependent mechanisms. These findings suggested potential important therapeutic value of barrier-protective oxidized phospholipids. In this study, we examined involvement of signaling complexes associated with caveolin-enriched microdomains (CEMs) in barrier-protective responses of human pulmonary ECs to OxPAPC. Immunoblotting from OxPAPC-treated ECs revealed OxPAPC-mediated rapid recruitment (5 minutes) to CEMs of the sphingosine 1-phosphate receptor (S1P1), the serine/threonine kinase Akt, and the Rac1 guanine nucleotide exchange factor Tiam1 and phosphorylation of caveolin-1, indicative of signaling activation in CEMs. Abolishing CEM formation (methyl-β-cyclodextrin) blocked OxPAPC-mediated Rac1 activation, cytoskeletal reorganization, and EC barrier enhancement. Silencing (small interfering RNA) Akt expression blocked OxPAPC-mediated S1P1 activation (threonine phosphorylation), whereas silencing S1P1 receptor expression blocked OxPAPC-mediated Tiam1 recruitment to CEMs, Rac1 activation, and EC barrier enhancement. To confirm our in vitro results in an in vivo murine model of acute lung injury with pulmonary vascular hyperpermeability, we observed that selective lung silencing of caveolin-1 or S1P1 receptor expression blocked OxPAPC-mediated protection from ventilator-induced lung injury. Taken together, these results suggest Akt-dependent transactivation of S1P1 within CEMs is important for OxPAPC-mediated cortical actin rearrangement and EC barrier protection.Keywords
This publication has 48 references indexed in Scilit:
- Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivoCritical Care, 2008
- The Therapeutic Effect of Oxidized 1-Palmitoyl-2-Arachidonoyl-sn-Glycero-3-Phosphorylcholine in Rodents With Acute Necrotizing Pancreatitis and Its MechanismPancreas, 2007
- Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout miceThe Journal of Experimental Medicine, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- The multiple faces of caveolaeNature Reviews Molecular Cell Biology, 2007
- Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protectionMicrovascular Research, 2007
- Caveolae, Lipid Rafts, and Vascular DiseaseTrends in Cardiovascular Medicine, 2005
- PDK1 and PKB/Akt: Ideal Targets for Development of New Strategies to Structure‐Based Drug DesignIUBMB Life, 2003
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001